Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
Technology
E-129-2001
Patent ID
E-129-2001-0-US-14
Country
US
Application Type
CON
Patent Status
Expired
Patent Number
8809502
Publication Number
US-2012-0258106-A1
Application Number
13/438,725
IC
NCI
Date Filed
Date Issued